Dr. Paul Alex Katigbak, MD

Dr. Katigbak practices at Berkshire Medical Center in Pittsfield, Massachusetts, part of Berkshire Health Systems.

Dr. Katigbak's NPI, 1417390410, was assigned on April 10, 2013. Dr. Katigbak graduated from Texas Tech University Health Sciences Center School of Medicine in 2013. Dr. Katigbak holds Texas license T1745.

Dr. Katigbak's primary practice is Berkshire Medical Center, at 725 North Street, Pittsfield, MA 01201 in Berkshire County. The practice phone is (413) 447-2000.

Dr. Katigbak's primary practice is Berkshire Medical Center in Pittsfield, Massachusetts, part of Berkshire Health Systems. Dr. Katigbak is also affiliated with Baystate Medical Center. The medical group on file is Berkshire Faculty Services. Dmand AI also links Dr. Katigbak to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katigbak practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Katigbak's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Katigbak is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Katigbak's licenses on file in 4 states: Texas, Massachusetts, Utah and Louisiana.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Katigbak treats.

CMS data shows 2,039 Medicare services from Dr. Katigbak across 18 procedure codes in 2024, for 1,447 Medicare patients. Medicare paid $70,890 for them.

CMS counts 1,447 Medicare patients who saw Dr. Katigbak in 2024. The largest group is 75 to 84, with 549 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katigbak's median patient age at 72, with 48% women.

In 2024, Dr. Katigbak wrote 1,660 Medicare Part D claims for 328 patients. 79% of them were for generic drugs. CMS names the drug for 1,563 of them, across 25 drugs with 11 or more claims each, at $279,008 in total drug cost. In 2023, CMS named 923 claims across 18 drugs.

Dr. Katigbak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Katigbak, published from 2011 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Coronary Stenosis, Coronary Vessels and Fractional Flow Reserve, Myocardial. Dr. Katigbak's most frequent co-authors are John C. Moscona, Anand M. Irimpen, MD and Rohan Samson, MD.

CMS Open Payments shows 30 general payments to Dr. Katigbak from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Lantheus Medical Imaging, Inc. paid the most, $316.

Dr. Katigbak graduated from Texas Tech University Health Sciences Center School of Medicine in 2013.

Dr. Katigbak is in network with 26 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.